Adv. 13/2026: Junior Research Fellow

RGCB; Northern (KY); Hybride; USD 3 700 - 4 800; Plein temps

Résumé du poste

Rajiv Gandhi Centre for Biotechnology (RGCB) in Thiruvananthapuram invites applications for a Junior Research Fellow to work on the IARC-WHO project evaluating HPV vaccine dosing efficacy. The selected candidate will operate in the Laboratory of Dr. Devasena Anantharaman under a Scientist F.

The position is based in Thiruvananthapuram. The candidate should hold a postgraduate degree in life sciences and have cleared CSIR-UGC NET, DBT-BET, or GATE, with research experience in cancer genomics and

Qualifications

• Post graduate degree in Life sciences is required.
• CSIR-UGC NET, DBT-BET, GATE or equivalent qualification is required.
• Familiar with research practices and methodologies and have knowledge in cancer genomics and bioinformatics.

Connaissances

Cancer genomics

Bioinformatics

Research experience

Formation

Postgraduate degree in Life sciences

Description du poste

Applications are invited from suitable candidates (Indian Citizens) for one positionof Junior Research Fellow to work in the IARC-WHO Project entitled “IARC-India HPVvaccination study to evaluate the effectiveness of one, two and three doses of quadrivalentHPV vaccine in preventing cervical neoplasia” in the Laboratory of Dr. Devasena Anantharaman,Scientist F, Rajiv Gandhi Centre for Biotechnology (BRIC-RGCB), Thiruvananthapuram.

EssentialQualifications

• The candidate must have a Post Graduate degree in any branch of Life sciences.
• The candidate should have qualified CSIR-UGC NET, DBT-BET, GATE etc
• The candidate must be familiar with research practices and methodologies and have good knowledge andexperience in one or more areas such as cancer genomics and bioinformatics.

Age

28 years as on 14 th October 2026. Age relaxation will be given as per Govt. of India norms

Duration

Initially for a period of one year or till termination of the project whichever is earlier and extendable based on the performance evaluation.